New test could help diagnose Alzheimer's disease in live patients
The patient turned 40 over the summer and was already having symptoms that made her neurologist wonder whether she had Alzheimer's disease, the deadly, mind-killing dementia that usually attacks far older people.
Alzheimer's disease & dementia
Dec 20, 2012 |
5 / 5 (2) |
0
FDA chief renews push for specialty pharmacy rules
(AP)—The head of the Food and Drug Administration renewed her push for new rules to help police pharmacies like the one that triggered a deadly meningitis outbreak, even as members of Congress expressed little interest ...
Health
Dec 19, 2012 |
not rated yet |
0
Better approach to treating deadly melanoma identified by scientists
(Medical Xpress)—Researchers funded by Cancer Research UK have been looking at why new drugs called "MEK inhibitors", which are currently being tested in clinical trials, aren't as effective at killing cancer cells as they ...
Cancer
Dec 19, 2012 |
not rated yet |
0
|
New computer model to speed development of drugs for heart failure
(Medical Xpress)—Researchers at the University of Virginia have developed a new model of how the heart reacts to stresses such as high blood pressure, shedding light on a common cause of heart failure and facilitating the ...
Medical research
Dec 13, 2012 |
not rated yet |
0
|
Automated design for drug discovery
A system of 'automated design' for new drugs could help develop the complex therapies needed for many medical conditions while also improving drug safety and efficiency, new research from the University of Dundee has shown.
Medications
Dec 12, 2012 |
5 / 5 (4) |
1
|
Improved treatments for chronic myeloid leukaemia have dramatically increased survival
Survival for people diagnosed with Chronic Myeloid Leukaemia (CML) has risen by nearly half, with around 58 per cent of people surviving their disease for at least five years compared with only around 40 p ...
Cancer
Dec 12, 2012 |
not rated yet |
0
Abiraterone benefits chemo-naive with advanced prostate CA
(HealthDay)—For chemotherapy-naive patients with metastatic castration-resistant prostate cancer, abiraterone acetate correlates with improved radiographic progression-free survival, according to a study ...
Cancer
Dec 12, 2012 |
not rated yet |
0
Sequencing project will map DNA of up to 100,000 patients
A new £100m project will map the DNA of up to 100,000 patients with cancer and other rare diseases.
Genetics
Dec 11, 2012 |
5 / 5 (2) |
0
New blood thinner may help prevent leg clots, study finds
(HealthDay)—The new anti-clotting drug apixaban (Eliquis) appears to help prevent potentially fatal blood clots in patients with deep vein thrombosis (DVT), a new Italian study finds.
Medications
Dec 10, 2012 |
5 / 5 (3) |
0
|
Antiseptic products can be contaminated, study says
(HealthDay)—Antiseptics are meant to keep bacteria and other pathogens from entering the body through breaks in the skin, but sometimes these products can be contaminated with the very organisms they're ...
Medications
Dec 06, 2012 |
4.5 / 5 (2) |
0
|
FDA pulls one generic form of wellbutrin off the market
(HealthDay)—People taking the antidepressant Wellbutrin now have one less option for a generic version of the drug.
Medications
Dec 06, 2012 |
5 / 5 (1) |
0
|
Longer life expectancy, aging population necessitate new strategies for prostate cancer care
The population of the United States is getting older, due not only to aging boomers but also to a four-year increase in life expectancy from 1990 to 2010. An aging population means increased diagnosis of prostate cancer. ...
Cancer
Dec 04, 2012 |
not rated yet |
0
Caution still advised despite ever-improving HIV drugs
Combination therapies for AIDS are becoming increasingly effective, but they cannot protect against other sexually transmitted illnesses. It is unsafe for patients taking antiretroviral drugs to stop using ...
HIV & AIDS
Nov 30, 2012 |
not rated yet |
0
Clinical trial delivers good results in leukemia patients
Huntsman Cancer Institute (HCI) researchers Michael Deininger, M.D., Ph.D., and Thomas O'Hare, Ph.D., were part of a team that found a potent oral drug, ponatinib, effective in patients who have developed resistance to standard ...
Cancer
Nov 30, 2012 |
not rated yet |
0
Ponatinib acts against the most resistant types of chronic myeloid leukemia
A previously invincible mutation in chronic myeloid leukemia (CML) has been thwarted by an investigational drug in a phase I clinical trial reported in the current edition of The New England Journal of Medicine.
Cancer
Nov 28, 2012 |
not rated yet |
0
|
